Q1 2026 · 13F-HR
PharVision Advisers, LLCholdings as filed
Filed 2026-04-22 · accession 0001420506-26-000696
$325,717
Reported value
7
Positions
2026-03-31
Period end
The Brief · PharVision Advisers, LLC · Q1 2026
AI · grounded in 13F
PharVision Advisers, LLC closed its position in EXLS, reducing exposure by $829,660. The fund also exited positions in DK and FVRR, totaling reductions of $723,912 and $703,970 respectively. To offset these sells, the fund initiated new positions in ACVA for $43,460, TTEC for $32,690, and CYH for $30,541.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 585464100 | MLCO | MELCO RESORTS AND ENTMNT LTD | $69,029 | 21.2% | 12,153 | Common | SOLE |
| 02128L106 | ALTG | ALTA EQUIPMENT GROUP INC | $60,638 | 18.6% | 11,292 | Common | SOLE |
| 91823B109 | UWMC | UWM HOLDINGS CORPORATION | $50,723 | 15.6% | 14,012 | Common | SOLE |
| 00091G104 | ACVA | ACV AUCTIONS INC | $43,460 | 13.3% | 10,250 | Common | SOLE |
| 68621F102 | ORGO | ORGANOGENESIS HLDGS INC | $38,636 | 11.9% | 16,302 | Common | SOLE |
| 89854H102 | TTEC | TTEC HLDGS INC | $32,690 | 10.0% | 13,076 | Common | SOLE |
| 203668108 | CYH | COMMUNITY HEALTH SYS INC NEW | $30,541 | 9.38% | 10,388 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.